- Advertisement -

Maximizing bioprocess efficiency through real-time cell density monitoring

insights from industryYavuz ÇelikGlobal Product ManagerHamilton Bonaduz AG In this interview, News Medical speaks with Yavuz Çelik, Global Product Manager at Hamilton, about how real-time...

Alzheimer’s Treatment Improved by Light-Activated Exosome Protein Delivery

Delivery of therapeutic proteins or other intracellular materials has been a long-standing challenge for translational medical researchers. Effective strategies can present a powerful tool...

Cytiva Completes Doubling of Utah Site’s Liquid Media Production Capacity

Cytiva has completed an expansion of its Logan, UT, facility that effectively doubles its liquid media production capacity, a project designed to support supply...

Accutar Biotechnology Announces First Patient Dosed in China with AC0682 in...

CRANBURY, N.J. & SHANGHAI--(BUSINESS WIRE)--Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, announces the dosing of the...

From Variability to Reliability: A New IgG4 Reference Standard for Consistent...

Register Now Panelists: Derrick Zhang Senior Scientist IIUS Pharmacopeia (USP) View Bio ...

Dx&Vx, Hanyang Institute of Bioscience and Biotechnology to co-develop new drugs...

Dx&Vx signed a memorandum of understanding on industry-university-research cooperation with the Hanyang Institute of Bioscience and Biotechnology (HY-IBB) on Tuesday. Dx&Vx CEO Park Sang-tae...

CDMOs Expand and Build for Future Growth

The top contract development and manufacturing organizations (CDMOs) have been busy in recent months expanding their service offerings, building new facilities, and navigating how...

BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C. auris

Bristol Myers Squibb has selected Houston as the site for a new $2.3 billion multi-modal manufacturing campus designed to support drug product and finished...

CDMOs Expand and Build for Future Growth

The top contract development and manufacturing organizations (CDMOs) have been busy in recent months expanding their service offerings, building new facilities, and navigating how...

BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C. auris

Bristol Myers Squibb has selected Houston as the site for a new $2.3 billion multi-modal manufacturing campus designed to support drug product and finished...

Thermo and Michael J. Fox Foundation Collaborate to Advance Proteomics-Enabled Parkinson’s Therapy

Thermo Fisher Scientific completed an Olink Explore HT proteomic analysis of approximately 5,500 research samples from the Michael J. Fox Foundation’s (MJFF) landmark study,...

more new items

CDMOs Expand and Build for Future Growth

The top contract development and manufacturing organizations (CDMOs) have been busy in recent months expanding their service offerings, building new facilities, and navigating how...

BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C. auris

Bristol Myers Squibb has selected Houston as the site for a new $2.3 billion multi-modal manufacturing campus designed to support drug product and finished...

Thermo and Michael J. Fox Foundation Collaborate to Advance Proteomics-Enabled Parkinson’s...

Thermo Fisher Scientific completed an Olink Explore HT proteomic analysis of approximately 5,500 research samples from the Michael J. Fox Foundation’s (MJFF) landmark study,...